Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages 481-486

  Vuppalanchi, Raj ^a   Ünalp, Aynur ^b   Van Natta, Mark L ^b   Cummings, Oscar W ^a   Sandrasegaran, Kumar E ^a   Hameed, Tariq ^a   Tonascia, James ^b   Chalasani, Naga ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY LIVER; FEMALE; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; PATHOLOGIST; SAMPLING; SCORING SYSTEM; SHOULDER PAIN;

ADULT; BIOPSY; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPECIMEN HANDLING;

EID: 62849123229     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.015     Document Type: Article

References (24)

1. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
2. Liangpunsakul S., and Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci 329 (2005) 111-116
3. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
4. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
5. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
6. Fassio E., Alvarez E., Dominguez N., et al. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40 (2004) 820-826
7. Harrison S.A., and Neuschwander-Tetri B.A. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8 (2004) 861-879 ix
8. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
9. Gramlich T., Kleiner D.E., McCullough A.J., et al. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 35 (2004) 196-199
10. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
11. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
12. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
13. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
14. Cholongitas E., Senzolo M., Standish R., et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 125 (2006) 710-721
15. Sherman K.E., Goodman Z.D., Sullivan S.T., et al. Liver biopsy in cirrhotic patients. Am J Gastroenterol 102 (2007) 789-793
16. Siddique I., El-Naga H.A., Madda J.P., et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 38 (2003) 427-432
17. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
18. Younossi Z.M., Gramlich T., Liu Y.C., et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 11 (1998) 560-565
19. Janiec D.J., Jacobson E.R., Freeth A., et al. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. Obes Surg 15 (2005) 497-501
20. Merriman R.B., Ferrell L.D., Patti M.G., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44 (2006) 874-880
21. Larson S.P., Bowers S.P., Palekar N.A., et al. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol 5 (2007) 1329-1332
22. Ratziu V., Charlotte F., Heurtier A., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (2005) 1898-1906
23. Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355 (2006) 2297-2307
24. McCullough A.J. Thiazolidinediones for nonalcoholic steatohepatitis-promising but not ready for prime time. N Engl J Med 355 (2006) 2361-2363